Trial Details

COMPLETED
Basic Information
Clinical ID c871
Identifier NCT00767728
Trial Title Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Granulated mesalamine|DRUG: Placebo
Participant Information
Sponsor Bausch Health Americas, Inc.
City Mexico
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-12-04
Primary Completion Date 2025-08-07
Completion Date 2025-10-07